Please assess the completion status of the following clinical trial:

Trial Title: Can Contrast-Enhanced Spectral Mammography Improve the Accuracy of a Diagnosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women called back from a screening mammography by either FFDM or tomosynthesis with soft tissue abnormalities including masses, asymmetries, focal asymmetries or architectural distortion with or without calcifications. Patients will be questioned regarding the possibility of pregnancy and will need a negative pregnancy test prior the study intervention.~Exclusion Criteria:~* Age \<30 years old~* Screening mammography with only calcifications abnormalities~* Male patients~* Pregnant or lactating patients~* Patients with any allergy to iodinated contrast~* Patients with eGFR \< 45~* Patients that may be treated with radioactive iodine

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Contrast-Enhanced Spectral Mammography (CESM) (Type: None): Women called back from an abnormal screening mammogram/tomosynthesis exam will be offered CESM as part of their diagnostic work up. The radiologist will interpret the low energy images and record their findings.

Based on this trial design, predict the completion outcome and termination type (if applicable).